Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Córdoba
Clinical trial register · Spain

Clinical Trials in Córdoba, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 188 Madrid 183 Seville 71 Málaga 66 Valencia 60
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca40 Novartis Pharmaceuticals22 Maimónides Biomedical Research Institute of Córdoba16 AbbVie16 Janssen Research & Development, LLC15 Clear sponsor filter
Site location
Barcelona188 Madrid183 Seville71 Málaga66 Valencia60
All 103 locations
Target enrolment
to

Trials with a site in Córdoba

40 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
AstraZeneca
Phase 3
2,800
Badajoz, Barcelona, Córdoba, Girona, Madrid, Majadahonda, Talavera de la Reina, Valencia
2026-09-01
Recruiting
AstraZeneca
Phase 3
7,000
Badajoz, Barcelona, Burgos, Córdoba, Granada, Madrid, Majadahonda, Málaga
2026-08-21
Recruiting
AstraZeneca
Phase 3
245
Barcelona, Córdoba, Galdakao, Madrid, Sabadell, Santander, Seville, Valencia
2026-04-13
Recruiting
AstraZeneca
Phase 3
1,100
A Coruña, Badalona, Barcelona, Córdoba, Donostia / San Sebastian, Girona, L'Hospitalet de Llobregat, Madrid
2025-12-29
Recruiting
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
NCT07201558Rheumatoid Arthritis, Systemic Lupus Erythematosus
DrugSurovatamig
AstraZeneca
Phase 1
48
Barcelona, Córdoba, Madrid
2025-12-02
Recruiting
AstraZeneca
Phase 3
800
Badalona, Barcelona, Córdoba, El Palmar (Murcia), L'Hospitalet de Llobregat, Madrid, Málaga, Oviedo
2025-08-01
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
DrugAZD0780
AstraZeneca
Phase 3
473
A Coruña, Barcelona, Córdoba, Reus, Seville
2025-06-10
Active, closed
AstraZeneca
Phase 3
3,103
A Coruña, Barcelona, Córdoba, Madrid, Santiago(A Coruña), Seville
2025-05-28
Recruiting
AstraZeneca
Phase 3
600
A Coruña, Córdoba, Donostia / San Sebastian, El Palmar, L'Hospitalet de Llobregat, Madrid, Palma de Mallorca, Valencia
2025-03-27
Recruiting
AstraZeneca
Phase 3
11,300
A Coruña, Barcelona, Córdoba, L'Hospitalet de Llobregat, Madrid, Málaga, Sant Joan Despí, Santiago(A Coruña)
2025-03-14
Active, closed
AstraZeneca
Phase 3
101
Alicante, Barcelona, Bilbao (Vizcaya), Córdoba, Donostia / San Sebastian, El Palmar, Girona, Madrid
2025-01-07
Active, closed
AstraZeneca
Phase 3
45
A Coruña, Alicante, Barakaldo, Barcelona, Córdoba, El Palmar, Girona, L'Hospitalet de Llobregat
2024-12-30
Recruiting
AstraZeneca
Phase 3
240
A Coruña, Barcelona, Córdoba, L'Hospitalet de Llobregat, Madrid, Sabadell, Valladolid
2024-06-20
Recruiting
AstraZeneca
Phase 3
5,250
Alicante, Badia Del Vallès, Barakaldo, Barcelona, Castro Urdiales, Córdoba, Granada, Madrid
2024-02-21
Active, closed
AstraZeneca
Phase 3
1,898
Barcelona, Córdoba, L'Hospitalet de Llobregat, Lugo, Madrid, Sabadell, Valencia
2023-11-21
Recruiting
AstraZeneca
Phase 3
800
A Coruña, Barcelona, Córdoba, Girona, Hospitalet deLlobregat, Madrid, Palma de Mallorca, Valencia
2023-09-22
Recruiting
OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain
NCT06068049Non-small Cell Lung Cancer
AstraZeneca
Observational
500
A Coruña, Alicante, Barcelona, C Rdoba, El Palmar, Girona, Granada, Jaén
2023-07-28
Recruiting
PICAROS - Acalabrutinib RWE on 1L CLL in Spain
NCT05999877Chronic Lymphocytic Leukemia
AstraZeneca
Observational
315
Almería, Córdoba, Granada, Jaén, Marbella, Málaga, Seville, Zaragoza
2023-07-11
Active, closed
AstraZeneca
Phase 3
111
Barcelona, Córdoba, Madrid, Pamplona
2023-06-27
Active, closed
AstraZeneca
Phase 3
594
A Coruña, Barcelona, Castellon, Córdoba, Hospitalet deLlobregat, Madrid, Málaga, Ourense
2022-09-15
Recruiting
AstraZeneca
Phase 2
454
Barcelona, Córdoba, Madrid, Málaga, Pamplona, Seville
2022-09-06
Active, closed
AstraZeneca
Phase 3
341
Badajoz, Badalona, Barcelona, Córdoba, Girona, Madrid, Majadahonda, Málaga
2022-08-03
Recruiting
AstraZeneca
Phase 2
630
A Coruña, Alicante, Barcelona, Córdoba, Madrid, Majadahonda, Málaga, Reus
2022-04-14
Active, closed
AstraZeneca
Phase 3
760
Barcelona, Córdoba, Donostia / San Sebastian, Madrid
2022-03-28
Active, closed
AstraZeneca
Phase 3
1,035
Barcelona, Córdoba, Lugo, Madrid, Málaga, Sabadell, Seville
2022-03-25
Active, closed
AstraZeneca
Phase 3
791
Bilbao (Vizcaya), Castellon, Córdoba, El Palmar, Palma de Mallorca, Sabadell (Barcelona)
2022-02-18
Active, closed
AstraZeneca
Phase 3
148
A Coruña, Barcelona, Córdoba, Madrid, Majadahonda, Málaga, Pamplona, Seville
2021-10-28
Active, closed
AstraZeneca
Phase 3
98
Alicante, Barcelona, Córdoba, León, Madrid, Málaga, Murcia, Oviedo
2021-09-12
Active, closed
AstraZeneca
Phase 3
640
Barcelona, Córdoba, Madrid, Pamplona, Santander, Zaragoza
2020-10-19
Active, closed
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
NCT04482309Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer, Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
DrugTrastuzumab deruxtecan
AstraZeneca
Phase 2
477
Barcelona, Córdoba, Madrid, Valencia
2020-08-18
Active, closed
AstraZeneca
Phase 3
185
Badalona, Barcelona, Córdoba, Donostia / San Sebastian, Granada, Madrid, Pamplona, Valencia
2020-08-04
Active, closed
AstraZeneca
Phase 3
866
A Coruña, Barcelona, Córdoba, El Palmar, Madrid, San Sebastián, Seville, Valencia
2020-07-24
Active, closed
AstraZeneca
Phase 3
818
A Coruña, Barcelona, Córdoba, Hosp de Llobregat(Barcelona), Jaén, La Laguna (Tenerife), Lleida, Madrid
2020-04-16
Active, closed
AstraZeneca
Phase 2
367
Córdoba, Donostia / San Sebastian, Madrid, Málaga, Valencia, Zaragoza
2019-01-09
Active, closed
AstraZeneca
Phase 3
1,407
Córdoba, Madrid, Terrassa(Barcelona), Vigo
2019-01-04
Active, closed
AstraZeneca
Phase 3
724
Córdoba, Madrid, Pamplona, San Sebastián(Guipuzcoa)
2018-11-30
Active, closed
AstraZeneca
Phase 3
1,063
Badalona, Barcelona, Córdoba, Las Palmas de Gran Canaria, Madrid, Santander, Seville
2018-11-16
Active, closed
AstraZeneca
Phase 3
1,837
A Coruña, Ávila, Badajoz, Badalona, Barcelona, Castellon, Cáceres, Córdoba
2014-04-22
Active, closed
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
NCT01874353Platinum Sensitive, BRCA Mutated, Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy
DrugOlaparib
AstraZeneca
Phase 3
327
Barcelona, Córdoba, Girona, Madrid, Pamplona, Valencia
2013-09-03
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
DrugOlaparib
AstraZeneca
Phase 3
450
Barcelona, Córdoba, Hospitalet deLlobregat(Barcelo, Madrid, Valencia
2013-08-26
Rows per page Showing 1–40 of 40
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/c-rdoba

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 40 of those studies with a site in Córdoba that also match the filters currently applied.

How many clinical trials are recruiting in Córdoba?

15 of the 40 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 25 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Córdoba), 40 studies
PhaseStudiesRecruitingShare
Phase 3331082.5%
Phase 24210%
Observational225%
Phase 1112.5%

Most active sponsors

Lead sponsors with the most studies (Córdoba)
Lead sponsorStudiesRecruiting
AstraZeneca4015
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.